Clinical Trial Update: A Clinical Trial to Evaluate the Safety, Tolerability and Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating M3T01 as a monotherapy and in combination with pembrolizumab and other systemic therapies for advanced solid tumors. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• M3T01
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Providence Health & Services | Conditions: Advanced Solid Tumors | Phase 1 | Status: RECRUITING